Impact of the black triangle label on prescribing of new drugs in the United Kingdom: lessons for the United States at a time of deregulation-Reference-Cited by-同舟云学术

Impact of the black triangle label on prescribing of new drugs in the United Kingdom: lessons for the United States at a time of deregulation

Published:2017-08-31 Issue:11 Volume:26 Page:1307-1313
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Horton Daniel B.¹²³^ORCID,Gerhard Tobias²³⁴,Davidow Amy⁵^ORCID,Strom Brian L.²⁶⁷

Affiliation:

1. Department of Pediatrics; Rutgers Robert Wood Johnson Medical School; New Brunswick NJ USA

2. Rutgers Center for Pharmacoepidemiology and Treatment Science; Institute for Health, Health Care Policy and Aging Research; New Brunswick NJ USA

3. Department of Epidemiology; Rutgers School of Public Health; Piscataway NJ USA

4. Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy; Rutgers University; Piscataway NJ USA

5. Department of Biostatistics; Rutgers School of Public Health; Newark NJ USA

6. Rutgers Biomedical and Health Sciences; Newark NJ USA

7. Department of Biostatistics and Epidemiology, Perelman School of Medicine; University of Pennsylvania; Philadelphia PA USA

Funder

Rutgers Biomedical and Health Sciences

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference29 articles.

1. Reporting adverse reactions: the black triangle and the patient;Drug Ther Bull,1983

2. Prescription-event and other forms of epidemiological monitoring of side-effects in the UK;Dunn;Clin Exp Allergy,1999

3. The yellow card scheme: guidance for healthcare professionals 2015 https://www.gov.uk/guidance/the-yellow-card-scheme-guidance-for-healthcare-professionals

4. Medicines under additional monitoring 2015 http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/document_listing/document_listing_000365.jsp

5. Underreporting of suspected adverse drug reactions to newly marketed (“black triangle”) drugs in general practice: observational study;Martin;BMJ,1998

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacists’ perception of educational material to improve patient safety;Medicine;2021-03-19

2. What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?;Pharmacoepidemiology and Drug Safety;2020-11-08

3. Impact of EU risk assessment process and administrative regulations for manufacturers of combined hormonal contraceptive prescribing. An analysis of developments in Germany and the implications;Current Medical Research and Opinion;2018-11-30